Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Bolt Biotherapeutics, Inc. (BOLT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/19/2021 |
3
| Lee Frank D. (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 11/19/2021 |
3
| O'CALLAGHAN BRIAN (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Perez Edith A. (Chief Medical Officer) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| LAPORTE KATHLEEN (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| SHAH MAHENDRA (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| HEALY JAMES (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| MILLER RICHARD A MD (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Khanna Ashish Siri Ram (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| ENGLEMAN EDGAR (10% Owner) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Moldt Peter (Director) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Yonehiro Grant (Chief Business Officer) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Dornan David (Chief Scientific Officer) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Novo Holdings A/S (10% Owner) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Quinn William P. (CFO) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 02/04/2021 |
3
| Schatzman Randall C (CEO) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
|
|